Cns Pharmaceuticals
(NASDAQ) CNSP
Cns Pharmaceuticals Financials at a Glance
Market Cap
$1.41M
Revenue (TTM)
$0.00
Net Income (TTM)
$13.07M
EPS (TTM)
$-58.07
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$2.32
Volume
124
Open
$2.40
Price
$2.32
Volume
124
Open
$2.40
Previous Close
$2.32
Daily Range
$2.24 - $2.40
52-Week Range
$2.06 - $34.80
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$2.32
Volume
124
Open
$2.40
Previous Close
$2.32
Daily Range
$2.24 - $2.40
52-Week Range
$2.06 - $34.80
CNSP News
CNSP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cns Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
5
CEO
John M. Climaco
Website
www.cnspharma.comHeadquarters
Houston, TX 77027, US
CNSP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-197%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.41M
Shares Outstanding
620.30K
Volume
124
Short Interest
0.00%
Avg. Volume
47.53K
Financials (TTM)
Gross Profit
$3.31K
Operating Income
$14.90M
EBITDA
$14.84M
Operating Cash Flow
$17.11M
Capital Expenditure
$4.19K
Free Cash Flow
$17.12M
Cash & ST Invst.
$6.46M
Total Debt
$326.07K
Cns Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$697.00
+7.2%
Gross Margin
0.00%
N/A
Market Cap
$1.41M
N/A
Market Cap/Employee
$352.02K
N/A
Employees
4
N/A
Net Income
$3.22M
+42.6%
EBITDA
$3.22M
+42.6%
Quarterly Fundamentals
Net Cash
$9.83M
+41.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$30.79K
-1.3%
Return on Assets
-1.10%
N/A
Return on Invested Capital
-1.33%
N/A
Free Cash Flow
$2.17M
+68.0%
Operating Cash Flow
$2.17M
+68.0%